iCoreConnect Inc. (NASDAQ:ICCT) Short Interest Update

iCoreConnect Inc. (NASDAQ:ICCT) was the recipient of a significant increase in short interest in March. As of March 31st, there was short interest totalling 374,600 shares, an increase of 822.7% from the March 15th total of 40,600 shares. Currently, 22.3% of the shares of the stock are sold short. Based on an average daily trading volume, of 15,360,000 shares, the short-interest ratio is currently 0.0 days.

iCoreConnect Price Performance

ICCT traded down $0.14 on Monday, hitting $3.87. 2,032,965 shares of the company were exchanged, compared to its average volume of 4,186,599. The business’s fifty day moving average is $1.81 and its 200 day moving average is $3.28. iCoreConnect has a fifty-two week low of $0.24 and a fifty-two week high of $27.80. The company has a debt-to-equity ratio of 7.93, a quick ratio of 0.11 and a current ratio of 0.11. The firm has a market capitalization of $8.02 million, a P/E ratio of -0.06 and a beta of -0.69.

Hedge Funds Weigh In On iCoreConnect

An institutional investor recently bought a new position in iCoreConnect stock. Virtu Financial LLC purchased a new position in shares of iCoreConnect Inc. (NASDAQ:ICCT) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 12,698 shares of the company’s stock, valued at approximately $32,000. Virtu Financial LLC owned about 1.04% of iCoreConnect as of its most recent SEC filing. Institutional investors own 13.42% of the company’s stock.

iCoreConnect Company Profile

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.